Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




New Surgical Approach for Bladder Cancer

By HospiMedica staff writers
Posted on 07 May 2001
New findings on advanced bladder cancer treatment suggest that transurethral resection with adjuvant therapy produces the same results as removing the bladder. More...
The findings were presented at the annual Update in Urology conference in Tampa (FL, USA) by Ralph deVere White, chair of the urology department at the University of California Davis Medical Center (Davis, USA).

The standard treatment for advanced bladder cancer is a radical cystectomy to remove the bladder, the lymph nodes and surrounding cancerous tissue. The new step-by-step approach, which has been offered to patients at the UC Davis Center for many years, calls for transurethral resection surgery to remove the bladder tumor, followed by additional surgeries to monitor cancer cell growth. Subsequent steps would depend on whether tissue samples test negative or positive for additional cancer. Adjuvant therapy is suggested to further improve survival. Cystectomy would remain an alternative..

Investigators at other institutions have also found that both approaches produce the same result. Dr. White believes the sequential approach could reduce the need for bladder removal by as much as 50%. "Based on these figures, we can save about half of the patients with invasive bladder cancer from a cystectomy and give them the same 10-year survival,” he noted.



Related Links:
Univ of California Davis Medical Center

Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Rapid Sepsis Test
SeptiCyte RAPID
POC Respiratory/Sore Throat Test
BIOFIRE SPOTFIRE (R/ST) Panel
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Medical Imaging

view channel
Images from patient T1, who had menstrual cycle–dependent right shoulder pain. (A) Maximum-intensity-projection images show abnormal findings for right diaphragm (arrowhead), bilateral round ligaments, peritoneum around bilateral ovaries, and left fallopian tube. Combined PET/MRI show hyperintense lesion with focal uptake inferior of right diaphragm, indicative of endometriosis (arrowhead, B). Confirmatory laparoscopy demonstrated extensive pelvic disease and implants of right diaphragm (C) that stained intensely positive for FAP (D).  (Image Credit: Schindler P, Brandt J, Bobe S, et al. Initial results of FAPI PET/MRI to assess the extent of endometriosis. J Nucl Med. 2026;67(8):1232–1238. doi:10.2967/jnumed.125.271376)

Targeted PET/MRI Improves Detection and Preoperative Mapping of Endometriosis

Endometriosis is a chronic inflammatory condition in which endometrial-like tissue grows outside the uterus, causing pelvic pain, infertility, and reduced quality of life. Conventional imaging can underestimate... Read more

Business

view channel
Image: Sempresto’s Smartphone-Integrated Epinephrine Auto-Injector Wins Red Dot Design Award (Photo courtesy of Sempresto)

Smartphone-Integrated Epinephrine Auto-Injector Concept Wins Red Dot Design Award

Severe allergic reactions can escalate rapidly and require prompt epinephrine, yet many at-risk patients do not consistently carry their auto-injector. With food allergies affecting an estimated 220 million... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.